Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
about
Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the futureRelevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver DiseaseNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsCassia cinnamon does not change the insulin sensitivity or the liver enzymes in subjects with impaired glucose tolerancePleurotus ostreatus opposes mitochondrial dysfunction and oxidative stress in acetaminophen-induced hepato-renal injury.Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease.Egg consumption and risk of non-alcoholic fatty liver disease.Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review.Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation.The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome.The Effects of Onion Consumption on Prevention of Nonalcoholic Fatty Liver Disease.Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial.Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway.Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
P2860
Q26777658-BC59A2F3-A243-4094-87CF-FC411C435027Q26778020-244648B3-6D9C-42A8-B8FF-87F635A490EAQ26796448-8A206648-D40D-4EBB-AB76-B7387EC2F32AQ34266920-76049B39-681B-4C54-825A-BA2B35CD7FC0Q34993617-18CB8870-4A10-4765-8173-0184C73B70C4Q35127037-4424DA93-03D9-4EC9-8D9D-D8246C8A22A4Q37119409-710684FF-37C9-42D8-A13B-5CDBF10B84F6Q37748010-BDB64C1D-06A1-429F-9BCD-97D3BB9F7B2DQ38808524-0ED42C75-E2A8-45FC-A33A-CC6BC5A38474Q39180593-631FEED2-DF72-4C33-97FD-0034E66DD267Q39311587-71F807B9-3EEB-4014-8483-B9FAF679B5E8Q40669013-E7BAB23F-F072-49D9-937E-CC14FBBE9473Q47300971-997EDD83-1020-4728-9266-3455D19FC00DQ48043740-09F28620-7139-4068-B79A-30AE98215A69Q48102672-22C87859-779A-4D8D-A846-D6884DB9FCA4Q50441886-9193931A-8A22-439E-B1E6-E7F0F588B5E4Q53625645-A5B781F4-7222-4F97-8C76-1C4255234763Q58753073-140E1619-4B3E-4958-8EC0-8B4E9613D48C
P2860
Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cinnamon may have therapeutic ...... fatty liver disease patients.
@en
Cinnamon may have therapeutic ...... fatty liver disease patients.
@nl
type
label
Cinnamon may have therapeutic ...... fatty liver disease patients.
@en
Cinnamon may have therapeutic ...... fatty liver disease patients.
@nl
prefLabel
Cinnamon may have therapeutic ...... fatty liver disease patients.
@en
Cinnamon may have therapeutic ...... fatty liver disease patients.
@nl
P2093
P1433
P1476
Cinnamon may have therapeutic ...... fatty liver disease patients.
@en
P2093
Azita Hekmatdoost
Bahram Rashidkhani
Faezeh Askari
P304
P356
10.1016/J.NUTRES.2013.11.005
P577
2013-12-06T00:00:00Z